Dr. Reddy's launches Aricept generic Donepezil

July 29, 2013 | Monday | News | By BioSpectrum Bureau

Singapore: Dr. Reddy's Laboratories has launched Donepezil Hydrochloride tablets, 23 mg, a therapeutic equivalent generic version of Aricept, 23 mg in the US market following the approval by the US FDA.

Aricept, 23 mg brand, indicated for the treatment of dementia, had US sales of approximately $92.6 million MAT for the most recent twelve months ending in May 2013, according to IMS Health.

Sign up for the editor pick and get articles like this delivered right to your inbox.

+Country Code-Phone Number(xxx-xxxxxxx)

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls